Legend Biotech Corp
A biotech company that develops and commercializes novel cell therapies for diseases.
LEGN | US
Overview
Corporate Details
- ISIN(s):
- US52490G1022
- LEI:
- Country:
- United States of America
- Address:
- 2101 COTTONTAIL LANE, 8873 SOMERSET
- Sector:
- Manufacturing
Description
Legend Biotech Corp. is a global, commercial-stage biotechnology company that discovers, develops, manufactures, and commercializes novel cell therapies. The company's primary focus is on treating life-threatening diseases, with a significant emphasis on oncology. Its lead product is CARVYKTI® (ciltacabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of relapsed or refractory multiple myeloma. This therapy is developed and commercialized in collaboration with Johnson & Johnson. Legend Biotech is building an end-to-end cell therapy platform to maximize patient access to its treatments and to advance its pipeline of cutting-edge cell therapy modalities for various diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Legend Biotech Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Legend Biotech Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Legend Biotech Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}